Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COLLEGIUM PHARMACEUTICAL, INC Director's Dealing 2017

Jun 2, 2017

32163_dirs_2017-06-02_01fcf7f9-f8b9-457a-ba16-155886c59806.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2017-05-31

Reporting Person: Ciaffoni Joseph (Chief Operating Officer)

Holdings (Non-Derivative)

Security Shares Ownership
No securities beneficially owned 0 Direct